Among these, anti-melanoma differentiation-associated gene 5 (MDA5) identifies a distinct clinical phenotype, often associated with clinically amyopathic dermatomyositis (CADM) and a predisposition to rapidly progressive interstitial lung disease (RP-ILD). Here, IFIH1 is linked to clinically amyopathic dermatomyositis.